Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suany Ojeda

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Virology|September 16, 2006
Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complexSuany Ojeda, Arban Domi, Bernard Moss
Journal of Virology|October 21, 2011
Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complexCindy L Wolfe, Suany Ojeda, Bernard Moss
Journal of Virology|March 21, 2008
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complexTimothy R Wagenaar, Suany Ojeda, Bernard Moss
Journal of Virology|December 15, 2005
Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L geneSuany Ojeda, Tatiana G Senkevich, Bernard Moss
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2005
Poxvirus multiprotein entry-fusion complexTatiana G Senkevich, Suany Ojeda, Alan Townsley, et al.
AIDS Research and Human Retroviruses|October 19, 2012
Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopesElizabeth S Russell, Suany Ojeda, Genevieve G Fouda, et al.
Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.
Journal of Virology|April 26, 2013
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen designLi-Hua Ping, Sarah B Joseph, Jeffrey A Anderson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Virology|September 16, 2006
Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complexSuany Ojeda, Arban Domi, Bernard Moss
Journal of Virology|October 21, 2011
Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complexCindy L Wolfe, Suany Ojeda, Bernard Moss
Journal of Virology|March 21, 2008
Vaccinia virus A56/K2 fusion regulatory protein interacts with the A16 and G9 subunits of the entry fusion complexTimothy R Wagenaar, Suany Ojeda, Bernard Moss
Journal of Virology|December 15, 2005
Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L geneSuany Ojeda, Tatiana G Senkevich, Bernard Moss
Proceedings of the National Academy of Sciences of the United States of America|December 13, 2005
Poxvirus multiprotein entry-fusion complexTatiana G Senkevich, Suany Ojeda, Alan Townsley, et al.
AIDS Research and Human Retroviruses|October 19, 2012
Short communication: HIV type 1 subtype C variants transmitted through the bottleneck of breastfeeding are sensitive to new generation broadly neutralizing antibodies directed against quaternary and CD4-binding site epitopesElizabeth S Russell, Suany Ojeda, Genevieve G Fouda, et al.
Plos Pathogens|October 10, 2022
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entryLalita Priyamvada, Wouter W Kallemeijn, Monica Faronato, et al.
Journal of Virology|April 26, 2013
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen designLi-Hua Ping, Sarah B Joseph, Jeffrey A Anderson, et al.
Pageof 1